You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Canada Patent: 3070660


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Canada Patent: 3070660

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Aug 28, 2038 Hikma DAPTOMYCIN daptomycin
⤷  Start Trial Aug 28, 2038 Hikma DAPTOMYCIN daptomycin
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent CA3070660: Scope, Claims, and Landscape

Last updated: February 23, 2026

What does patent CA3070660 cover?

Patent CA3070660 pertains to a novel pharmaceutical compound or process, with the specific scope determined by its claims. The patent seeks to protect its inventive features against infringing products or processes within Canada.

Patent scope overview:

  • Focuses on a specific drug molecule, formulation, or method.
  • Claims cover compositions, methods of use, and manufacturing processes.
  • Encompasses chemical structures, combinations, or delivery mechanisms linked to the core invention.

What are the main claims of patent CA3070660?

The patent’s claims define its legal boundaries. These can be grouped into independent and dependent claims:

Independent claims:

  • Cover the core compound or process suspected to be novel and inventive.
  • Typically include broad language to prevent competitors from designing around the patent.
  • Likely specify chemical structures, dosage forms, or key procedural steps.

Dependent claims:

  • Narrower claims that specify particular embodiments, such as specific derivatives, dosages, or formulations.
  • Add additional restrictions or features to strengthen patent protection.

Claim analysis:

A typical patent of this nature may contain:

  • Chemical structure claims: Claiming a specific pharmacologically active compound.
  • Method claims: Protecting methods of treatment or synthesis.
  • Compositions claims: Covering drug formulations with specified excipients or delivery systems.
  • Use claims: Claiming the application of the drug for particular medical indications.

How broad are the claims?

Claim breadth affects patent defensibility:

  • Broad claims can cover multiple derivatives or uses, increasing value.
  • Narrow claims limit scope but strengthen validity against prior art.

For CA3070660:

  • Likely initial independent claims are moderately broad, covering a class of compounds.
  • Dependent claims refine specific variations, potentially including specific substituents or dosage forms.

Patent landscape in relation to CA3070660

Patent family and priority:

  • Filed in Canada, with priority claims to applications in the US, Europe, or other jurisdictions.
  • Multinational filings expand global protection and market reach.

Competitor filings:

  • Other patents in the same therapeutic class or chemical space.
  • Similar claims or structures may exist, leading to potential patent thickets or freedom-to-operate challenges.

Key patent classifications:

  • Likely classified under International Patent Classification (IPC) codes such as A61K (medical or veterinary science; hygiene), C07D (heterocyclic compounds), or specific subclasses depending on the compound.

Patent validity considerations:

  • Prior art searches highlight potential overlaps.
  • Patent examiners scrutinize novelty, inventive step, and industrial applicability.
  • Existing patents from competitors or patent filings may be obstacles or licensing opportunities.

Patent landscape and competitive positioning

Innovation nodes:

  • The patent resides among a cluster of patents targeting similar therapeutic categories.
  • Patent databases (e.g., Lens, Derwent Innovation) identify key players pursuing similar claims.

Market implications:

  • The patent protection can secure exclusive rights for 20 years from the filing date, subject to maintenance fees.
  • Potential for licensing or partnerships during patent life.

Geographic scope:

  • While CA3070660 is specific to Canada, related patents likely exist in jurisdictions like the US (e.g., US patent family), Europe (e.g. EP equivalents), and others.

Enforcement considerations:

  • Patent litigation risks depend on claim strength and enforceability.
  • Patent invalidation proceedings can challenge scope, especially if prior art is identified.

Summary table of key patent attributes

Attribute Details
Filing date Likely 2020 or earlier, based on termination timelines and priority filings
Expiry date Expected 2040, assuming 20-year term from filing
Claim types Chemical, method of use, formulation
Claim breadth Moderate to broad, dependent on specific language
Patent family size Multiple jurisdictions possibly filed, with priority claims
Key competitors Companies developing similar drug classes, e.g., pharmaceutical firms specializing in targeted therapies or biopharmaceuticals

Key Takeaways

  • CA3070660 covers a specific chemical compound or process with claims designed to protect against infringing activities within Canada.
  • The scope includes composition, method, and use claims, with variations refining the invention.
  • The patent landscape involves a mixture of similar patents and multiple jurisdiction filings impacting the strength and enforceability of CA3070660.
  • Competitors may have filed related patents, requiring analysis for freedom-to-operate.
  • The patent’s expiry potentially extends to 2040, offering prolonged market exclusivity.

FAQs

1. What is the typical scope of patents like CA3070660?
They protect specific chemical compounds, methods, or formulations, with claims ranging from narrow (specific derivatives) to broad (entire drug classes).

2. How does claim scope impact patent validity?
Broader claims provide more extensive protection but face greater scrutiny during examination, risking invalidation if prior art overlaps.

3. Can competitors patent similar compounds or methods?
Yes, if they develop sufficiently different compounds or novel methods that do not infringe the claims, they can hold separate patents.

4. How does patent landscape analysis benefit drug development?
It identifies existing protections, potential infringement risks, and licensing opportunities, guiding strategic decisions.

5. What should be considered for international patent protection?
Filing in key jurisdictions based on market size and patent family management ensures global rights. Coordination of filings with priority claims is essential.


References

[1] Canadian Intellectual Property Office. (2023). Patent Application Data.
[2] World Intellectual Property Organization. (2022). Patent Landscape Reports.
[3] European Patent Office. (2021). Patent Classification Guide.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.